FDA Import Refusal AEK-3212939-5/31/1 — Novartis Pharma AG
The FDA refused shipment AEK-3212939-5/31/1 from Novartis Pharma AG (Switzerland) on May 3, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 3, 2023
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 66VIY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75